Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis B.
Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis B.
复制标题
DOI:
10.1371/journal.pone.0111641
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Pan JS
中科院分区:
文献类型:
--
作者:
Hong MZ;Zhang RM;Chen GL;Huang WQ;Min F;Chen T;Xu JC;Pan JS
Liver biopsy is indispensable because liver stiffness measurement alone cannot provide information on intrahepatic inflammation. However, the presence of fibrosis highly correlates with inflammation. We constructed a noninvasive model to determine significant inflammation in chronic hepatitis B patients by using liver stiffness measurement and serum markers. The training set included chronic hepatitis B patients (n = 327), and the validation set included 106 patients; liver biopsies were performed, liver histology was scored, and serum markers were investigated. All patients underwent liver stiffness measurement. An inflammation activity scoring system for significant inflammation was constructed. In the training set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.964, 91.9%, and 90.8% in the HBeAg(+) patients and 0.978, 85.0%, and 94.0% in the HBeAg(−) patients, respectively. In the validation set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.971, 90.5%, and 92.5% in the HBeAg(+) patients and 0.977, 95.2%, and 95.8% in the HBeAg(−) patients. The liver stiffness measurement-based activity score was comparable to that of the fibrosis-based activity score in both HBeAg(+) and HBeAg(−) patients for recognizing significant inflammation (G ≥3). Significant inflammation can be accurately predicted by this novel method. The liver stiffness measurement-based scoring system can be used without the aid of computers and provides a noninvasive alternative for the prediction of chronic hepatitis B-related significant inflammation.
登录
查看更多内容
DOI:
10.1186/1476-5926-3-8
发表时间:
2004-09-23
期刊:
Comparative hepatology
影响因子:
--
作者:
Poynard T;Imbert-Bismut F;Munteanu M;Messous D;Myers RP;Thabut D;Ratziu V;Mercadier A;Benhamou Y;Hainque B
通讯作者:
Hainque B
影响因子:
168.9
作者:
Imbert-Bismut, F;Ratziu, V;Poynard, T
通讯作者:
Poynard, T
影响因子:
2.5
作者:
Coco, B.;Oliveri, F.;Brunetto, M. R.
通讯作者:
Brunetto, M. R.
影响因子:
24.5
作者:
Foucher, J;Chanteloup, E;de Lédinghen, V
通讯作者:
de Lédinghen, V
影响因子:
2.8
作者:
Cho, Hyo Jung;Kim, Soon Sun;Cheong, Jae Youn
通讯作者:
Cheong, Jae Youn